Clinical Trial Update: Allogeneic Transplantation of Expanded Pancreatic Islet Cells [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on allogeneic transplantation of expanded pancreatic islet cells for brittle Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Expanded pancreatic islet cells (allogeneic transplantation)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Brittle Type 1 Diabetes | Phase 2 | Status: UNKNOWN